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Abstract
Background: Conducting clinical trials with pre-term or sick infants is important if care for this population is to be
underpinned by sound evidence. Yet, approaching the parents of these infants at such a difficult time raises
challenges to obtaining valid informed consent for such research. In this study, we asked, What light does the
analytical literature cast on an ethically defensible approach to obtaining informed consent in perinatal clinical
trials?
Methods: In a systematic search, we identified 30 studies. We began our analysis by applying philosophical
frameworks, which were then refined as concepts emerged from the analytical studies, to present a coherent
picture of a broad literature.
Results: Between them, the studies addressed four themes. The first three were the ethical basis for parental
informed consent for neonatal and/or perinatal research, the validity of parental consent in this context, and the
range of possible options in methods for gaining consent. The last was the issue of risk and the possibility of a
double-standard or asymmetry in the current approaches to the requirement for consent for research and consent
for clinical treatment.
Conclusions: In addressing these issues, the analysed studies showed that, whilst there are a variety of possible
defences for seeking parental ‘consent’ to neonatal and/or perinatal clinical trials, these are all consistent with the
strongly and widely held view that it is important that parents do give (or decline) consent for such research. So far
as the method of obtaining consent is concerned, none of the existing consent processes reviewed by the research is
satisfactory, and there are philosophical reasons for supposing that at least some parents will fail to give valid consent
in a neonatal context. Furthermore, in giving parental ‘consent’ in a perinatal context, parents are authorising infant
participation, not giving ‘proxy consent’. Finally, there are reasons for giving weight to both parental ‘consent’ and the
infant’s best interests in both research and clinical treatment. However, there are also reasons to treat these factors
differently in the two contexts, and this may be partly due to the differing relevance of risk in each case. A significant
gap is the lack of any detailed discussion of a process of emergency and/or urgent ‘assent’, in which parents assent or
refuse their baby’s participation as best they can during the emergency and later give full consent to continuing
participation and follow-up.
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Background
The recruitment of pre-term or sick infants to trials
requires approaching parents at a particularly difficult
time, often within a tight time frame for making a deci-
sion. This raises challenges for the obtaining of valid
informed consent to such research. But given the im-
portance that has been attached by codes of ethics to
gaining informed consent for clinical research, if the
problem of consent cannot be successfully addressed,
there is a risk of this becoming an ‘orphan’ area of re-
search. That is, if ethically permissible research cannot
be designed, then this area of medical research will be
abandoned.
This paper reports on analytical research examining
and addressing these difficulties. We undertook two sys-
tematic reviews of the research addressing these ethical
challenges within the context of a larger project focused
on improving care for the pre-term infant. These reviews
had as their goal the identification of both the ethical
challenges and potential solutions. The aim of the review
of the empirical research was to synthesise observational
and qualitative studies that explored the process of re-
cruitment and consent, and parents’ and clinicians’ views
and experiences of that process [1].
The present review is a complementary paper whose
aim is to synthesise analytical (or philosophical) studies
which have examined the pertinent ethical questions.
These concern the validity of consent, the proper under-
standing of the parental role in giving or withholding
consent, varied possible methods of seeking consent, the
best interests of those involved, issues of risk, and the
parallels between consent processes in relevant research
and clinical contexts.
The review process for the two papers, empirical and
analytical, involved a common literature search and
common elements in the development of the conceptual
framework which both guided that search and was in-
formed by its results. The process then involved initially
identifying papers found in the search as empirical or
analytical and, once that initial distinction had been
made, proceeding in two separate processes of identify-
ing more precisely relevant themes and then coding
papers. In the light of the common features in the devel-
opment of these two reviews, there is inevitably some
overlap between this analytical paper and the empirical
paper [1], both in setting out the broad context and in
describing the method for the research.
The use of a systematic review for addressing prob-
lems in medical ethics is methodologically novel, per-
haps particularly so with respect to the treatment of
analytical papers [2–4]. In philosophy, the standard way
to engage with analytical papers is to subject their argu-
ments to scrutiny rather than to synthesise their main
claims. The method of systematic review as developed in
the social and medical sciences is designed, it would
seem, to achieve objectivity and impartiality in arriving
at a synthesis of results of research in a given field. Phi-
losophers might claim that the method of analysing and
developing arguments achieves a similar objectivity and
lack of bias in virtue of the impartial nature of the ana-
lysis and development of arguments. Having said that,
there is a methodological tradition in philosophy, going
back to the Greeks [5, 6], which suggests that, in any
inquiry, the appropriate place to start is by reviewing the
‘phainomena’, and these phainomena include the existing
views of both the ordinary person and the wise on the
topic in question. Given the very large output of analyt-
ical papers in contemporary research, such a compre-
hensive review of the phainomena is perhaps less
common and would arguably be hard to fulfil on some
topics. So it might be said that the standard method of
analytical engagement with analytical papers does run
the risk of considering only a narrow perspective on an
issue. Thus, to that extent, it also runs the risk of a cer-
tain sort of bias, a bias that the methods adopted in a
systematic review do help to avoid.
The aim of the present paper is to synthesise the key
strands of philosophical argument that have been put
forward with respect to consent in neonatal research,
rather than to engage dialectically with them. For clini-
cians, the key ethical question is practical: “What is the
right thing to do here?” That is a central ethical ques-
tion, but it is also important for clinicians to ask why a
course of action is right, and the analytical literature is
focused on that.
Our research has been undertaken by a multi-
disciplinary team of philosophers, clinicians, social sci-
entists and information scientists who have brought
complementary skills to the task. So, this process of
developing a systematic review in ethics through
inter-disciplinary collaboration has given rise to consider-
able reflection in its own right. These unpublished obser-
vations of authors of this paper are being collated.
However, in this paper, no significant space is given to
detailed further reflection on that process.
The paper begins by setting out a brief summary of an
iterative process for making sense of a body of literature
via a framework synthesis, then gives an account of the
results, and concludes with a discussion of some of the
key points arising from the results. Our overarching
question was, What light does the analytical literature
cast on an ethically defensible approach to obtaining in-
formed consent in perinatal research?
In broad outline, the method adopted for this review
conformed to that set out for a framework synthesis in
Gough et al.’s recent account of systematic reviews [7].
The first stage was the development of a tentative initial
conceptual framework1 which relied mainly on prior
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knowledge of the existing philosophical literature on
informed consent (prominent books and papers). This
included knowledge of material that was more specific-
ally focused on the difficulties of gaining informed con-
sent in neonatal research [8, 9]. This initial conceptual
framework informed the criteria for including studies
and suggested terms for the first literature searches.
The initial conceptual framework was then refined in
light of the literature uncovered by the first searches
(stage 2 in Gough et al.’s account [7]) and the multiple
perspectives offered by the backgrounds of the authors.
The second searches were then developed, informed by
the now-confirmed conceptual framework. Searches
were run on a wider set of resources to address the
multidisciplinary nature of the review. At stage 3, the
task of coding articles was undertaken, and this led to
stage 4, the tabulating of the data. The final stage was then
drawing conclusions from the tabulated data (stage 5).
Methods
The aim of the searches was to identify studies for a re-
view of ethical issues around consent that arise from the
involvement of either pre-term babies or sick neonates in
clinical trials. The first literature searches were undertaken
in July 2011 in MEDLINE (Ovid) and Philosopher’s Index
(Ovid). The terms and synonyms for the search were
informed by the initial conceptual framework and the pro-
ject team’s suggestions. The information specialist identi-
fied subject headings and constructed search strategies by
combining search terms and subject headings.
Articles potentially eligible for inclusion were those
reporting consent and decision-making in various peri-
natal or related contexts:
1. Any empirical research or analysis and/or
commentary concerning the following:
a. Consent, participation or recruitment for
neonatal research
b. Parental decision-making for treatment of, or
research with, sick or pre-term neonates
c. Parental decision-making for birth and/or labour
d. Methodology in emergency and/or urgent
research
e. Alternative ways of gaining consent
2. Full text available in English
Titles and abstracts, and subsequently full texts, were
retained only if they matched the inclusion criteria. Arti-
cles were screened by a researcher with clinical and ethics
expertise (EW) who adopted an overinclusive approach to
avoid losing any relevant studies; in case of any doubt, the
decision was discussed with a philosopher (CM).
The ‘included’ articles were then separated into ‘empir-
ical’ (quantitative or qualitative research) and ‘analytical’
(philosophical discussion or commentary) categories.
The ‘analytical’ papers which were identified as poten-
tially relevant after screening the output of the first sys-
tematic search were re-read to identify recurrent
themes. Draft summaries of each theme were then dis-
tributed to the steering group, which comprised a social
scientist, another clinician, a lay representative and the
information specialist. They confirmed the conceptual
framework.
Further searches were devised with attention to the
confirmed conceptual framework. These second searches
were conducted in October 2011 on 11 databases (see
Additional file 1). The aim of these searches was to iden-
tify studies of relevance to the review themes despite
coming from different disciplines (e.g., obstetrics, foetal-
maternal medicine, neonatology, social science, bioeth-
ics). The additional databases were chosen on the basis
of their availability and the advice offered in the litera-
ture on bioethics studies retrieval [3, 4, 10, 11]. The
search terms were informed by the confirmed conceptual
framework and by terms suggested in bioethics review
methods studies [3, 4, 10]. Update searches were con-
ducted in January 2014 in all previously chosen databases.
Additional file 1 shows an example search strategy.
The results of the second searches were then consid-
ered. Papers from these references were screened, and
‘included’ or ‘excluded’, on the basis of abstracts using
the inclusion criteria set out above. However, in this sec-
ond screening, the review team demanded, in addition,
very definite positive reasons to include further papers.
There had to be clear indications that some new insights
were being added to those we already had from the ini-
tial set of papers. In the absence of such new insights,
the research findings were viewed as saturated. In the
next stage (stage 3), the findings of these included ana-
lytical papers were coded according to the confirmed
conceptual framework, including emergent themes, and
tabulated to provide a summative identification of the
key ethical points made in the papers analysed.
Results
The Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) diagram (Additional file
2) illustrates the flow of studies throughout the review.
In the searches, we identified 1361 records (234 from
the first searches, 790 from the second round and 327
from the update searches). A set of 27 papers identified
from the first searches met the original inclusion criteria.
Expanding the databases and introducing new search
terms while narrowing the scope (second searches) led
to a total of 30 analytical papers being ‘included’. Recur-
rent themes were identified in the literature (Table 1).
Table 2 presents the themes covered by papers
included in the review and the context in which the
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arguments were developed. The table includes only the
papers which were first to identify a unique theme and
research context. Subsequent papers are not shown, as
Table 2 displays the themes present within different
research contexts and does not quantify the number of
papers per theme and context. However, all the papers
are referred to in the results prose and in the tabulated
results (Additional file 3).
In what follows, first of all, we present these tabulated
results in prose form, and then, in the last section, we
discuss the conclusions drawn from those results.
The ethical basis for (parental) informed consent in
neonatal and/or perinatal research
The focus of the analytical papers which addressed the
issue of parental informed consent in the neonatal and/
or perinatal context was on the question of the nature of
the justification for seeking consent from a parent (or
parents). This issue arises because it may be thought
that it is not sensible to seek consent when the most af-
fected party is unable to give consent. It might be sug-
gested that the focus should simply be on that
individual’s best interests. This approach might be but-
tressed by querying the basis for consent being given by
another, in this case the parent.
So, one claim is that, where children are unable to give
or decline consent, parents should do so. A number of
justifications are offered for this. Some are based on an
appeal to the importance of autonomy. Different forms
of the appeal to autonomy are then made.
One view put forward appeals to the importance of
parental autonomy, or the parents’ own rights, in this
context [12, 13]. Thus, it is held that making decisions
about a child is part of what it is to be a parent [14] or,
alternatively (or in addition), that respecting parental au-
tonomy here is part of respecting a ‘privacy’ right of the
parent [15]. A similar but slightly different claim holds
that parenting decisions are part of deciding how to con-
duct one’s own life [13, 15], whilst another defence sug-
gests that foetal rights are a function of maternal
autonomy [16].
However, others have rejected any defence of parental
consent that appeals to autonomy. They have objected
that a parent’s interest in autonomous parenting may
not outweigh the child’s interests [15], or that parents
are no longer ‘owners’ of their children [17].
A second claim in defence of parental consent is that
parents should be seen as surrogate or proxy decision
makers [13]. Thus, it has been suggested that when a
child is not yet autonomous, the parent is the most ap-
propriate ‘proxy’ [18], where a ‘proxy’ means not simply
someone who acts on behalf of another but one who
represents another’s views. A general defence for this is
that the parent may be in the best position to have
knowledge of the child’s personality, values and beliefs,
but this claim is noted to apply only to the case of older
children, not to that of neonates [18].
Some suggest there might be reason for a parent to
give consent even if an appeal to autonomy or rights is
rejected. Thus, it is held that (1) it is not appropriate to
think of the ‘autonomy’ of a neonate [17, 18], and there-
fore (2) it is not appropriate to think of ‘informed con-
sent’ for a child [14].
Another line of argument is that consent in the neo-
natal context should be seen as a case of ‘family
decision-making’, because it is not appropriate to con-
sider the child’s decision in isolation [14]. In addition, it
is suggested that parents should give consent because
parents will bear the consequences of the decision [13].
However, some claim that the requirement for parental
consent rests on the value of beneficence. Thus, the pur-
pose of informed consent is said to be the protection of
the best interests of the child, and it is the responsibility
of parents to make decisions as a way of promoting their
child’s best interests [13, 19], so they should give con-
sent. Or it is said that parents are most likely to have the
child’s best interests at heart [15, 20], or that parents are
the best judges of their child’s best interests [15, 17, 18,
20]. (Some object to this, that such a justification is pru-
dential and therefore insecure; that is, it is suggested
that, in the often traumatic context in which parents are
consulted about neonatal research, they often may not
be the best judge of their child’s interests [15].) In a related
but slightly different vein, some have argued that parents
should only be allowed to make the decision when it is in
the best interests of their child [13, 14, 17, 20].
In reply to this, it is argued that the protection of the
child’s best interests should not rest entirely or even
Table 1 Recurrent themes and their elaborations
Theme Elaboration
The ethical basis of parental informed consent for
neonatal research
The ethical reasons put forward for the importance of gaining parental consent for neonatal
research
Validity of parental consent Discussion of the requirements to be met if parental consent given is to be viewed as
genuine informed consent
Other options for gaining consent Discussion of different possible methods for gaining consent
Risk and the double-standard between consent for
treatment and consent for research
The ethically defensible level of risk to which a neonate undertaking research might be
exposed and comparisons with the approach to risk and consent in treatment
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Table 2 Themes and context of the philosophical arguments
Themes revealed
Ethical basis for
consent
Validity of consent Issues of risk Other options for
consent
Miscellaneous topics
Context in which philosophical
arguments have been developed
Emergency neonatal
research
Manning, 2000 [24] Manning, 2000 [24]
Perinatal clinical
decision-making
Pinkerton et al.,
1997 [20]
Foetal-maternal
research
American College of Obstetricians
and Gynecologists, Committee on
Ethics; American Academy of
Pediatrics, Committee on Bioethics,
2011 [26]
American College of Obstetricians
and Gynecologists, Committee on
Ethics; American Academy of
Pediatrics, Committee on Bioethics,
2011 [26]
Neonatal clinical
decisions
Rostain and
Bhutani, 1989 [13]
Rostain and Bhutani, 1989 [13] Rostain and
Bhutani, 1989 [13]
Schneider, 1988
[15]
Neonatal research McDonnell, 1990
[14]
Silverman, 1988 [29] Silverman, 1988
[29]
Silverman and
Altman, 1996 [35]
Silverman and
Altman, 1996 [35]
Tyson and
Knudson, 2000 [32]
Tyson and
Knudson, 2000 [32]
Allmark, 1999 [40]
Vain et al., 2004
[38]
Perinatal emergency
research
Vain et al., 2004
[31]
Trials in general (but
discusses ECMO)
Worrall, 2008 [39]
Braunholtz, 1999
[41]
ECMO Extracorporeal membrane oxygenation
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mainly on informed consent [12, 17]. It is the responsibil-
ity of the researcher or the ethical review process to pro-
tect the subject’s best interests (so it is inappropriate to
defend parental consent by an appeal to the protection of
those interests). Others have claimed that determining
what is meant by the best interests of a neonate is not
simple. There are different accounts of best interests—the
mental state account, the desire satisfaction account, and
the objective list view. Even if the right account as
between these is agreed, the application of at least some
such accounts to a neonate is challenging [21].
A further general response to the parental consent
view notes that the concept of parental consent is a
misnomer here. In the case of neonates, what should
be discussed is the concept of parental permission (or
authorisation) [17].
The validity of consent
As in the empirical research we examined, an important
theme in the analytical research is the question whether,
in the neonatal and perinatal context, parental consent
is valid, and to what extent the validity of the consent
matters. One aspect of this is the potential barriers to
obtaining valid consent in these circumstances [22]. One
factor noted is the time limitations that will regularly
occur. Such a time limit will adversely affect the amount
and quality of the information given [23, 24], and, cor-
respondingly, a time limit will harm the parental under-
standing of any information given [24].
A second point addresses the stress, anxiety or pain of
the parents, as well as the mother’s sedation [23, 25]. It
is argued that this can adversely affect understanding
[23–25] or capacity [23, 25]. However, some writers have
claimed that these features can also contribute (posi-
tively) to an autonomous decision process [13].
A third impediment to valid consent that has been
identified is the potential desperation or fear of the par-
ents [23, 24, 26]. These emotional states will affect the
voluntariness of any consent given (presumably through
acting as forms of psychological coercion) [24, 25, 27]. A
fourth line of argument is that the researcher may very
often be seen by parents as a figure of authority or
power, and that this also has a coercive effect on the par-
ents which affects the voluntariness of the decision [28].
A slightly similar argument claims that the consent
process itself, through undermining the individuals’ ap-
preciation of their own competence, is an indirect obs-
tacle to autonomy and thus to genuine consent [25].
Another line of argument which identifies a more indir-
ect problem for gaining valid consent is that the consent
process itself increases parental anxiety (and thus affects
valid consent) [24].
Discussions of this theme also consider the implica-
tions of the existence of barriers to informed consent in
the context of neonatal or perinatal research. Some ad-
dress the implications of these barriers for respect for
the principle of autonomy if, in light of the discussions
identified in the first theme, that is the basis for seeking
parental consent. Some argue that parental autonomy
will be violated if there is a defect in the consent process
[24], while others adopt a Kantian perspective and sug-
gest that parents are being used as a means to an end
(not as a member of the ‘Kingdom of Ends’, in Kant’s
terms) in a consent process which is flawed in any of the
ways identified above [24].
A further argument, building on these problems, is
that the principle of beneficence (acting for the benefit
of the child and/or mother) becomes a more important
ethical principle in research with neonates because in-
formed consent is not possible (and therefore any appeal
to autonomy or respect for persons should be applied
with caution) [27]. However, another response to the dif-
ficulties with and barriers to consent is that we must
strive for improvements in what we do to seek consent
and must attempt to get the best possible consent even
where perfect informed consent is not possible [17]. But
one worry raised about this way of proceeding is that the
residual difficulties will make it the case that deprived or
uneducated parents will be more likely to consent. This
will therefore mean, it is claimed, both that the practice of
neonatal research involves an unjust allocation of any bur-
dens which such research involves and that, from a meth-
odological point of view, any conclusions drawn from the
research may not be generalisable [24, 29].
Issues of risk in neonatal and perinatal research and the
possibility of double-standards, or disanalogies, or
asymmetries, between consent for research and consent
for clinical treatment
The analytical research has also examined a cluster of is-
sues around the treatment of risk in medical research
and clinical treatment, and somewhat related matters
about differences or parallels in the way in which de-
cisions are reached in clinical and research contexts.
Although these are more general issues, they all bear
directly on the treatment of risk, consent and best in-
terests in neonatal and perinatal research.
There are disagreements about the nature of the risks
involved in research. One claim is that if the context for
the clinical trial is a potentially life-threatening condition
for the subject, and the outcome of the intervention is
unknown, then the trial treatment or intervention
should itself be viewed as a significant risk for the sub-
ject [30]. An opposing claim is that if the context for the
trial is a potentially life-threatening condition, then this
is a risk of the disease and/or the situation, and not of
the trial, so it should not be viewed as a risk of the trial
intervention [31]. A third, somewhat related claim about
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risk in trials is that fully informed consent is not possible
for clinical trials because the very information needed
for fully informed consent is that which is uncertain and
under investigation [32].
There are then a series of claims as to the parallels be-
tween the two areas of practice, or their absence, and
these may in part be to do with the evaluation of risk in
each context. Thus, it is claimed that in clinical deci-
sions the principle of beneficence tends to trump other
ethical considerations, but in research decisions the
principle of autonomy trumps considerations of interest
[33]. This is conjectured to hold firstly because the two
types of consent process evolved separately [29] (with
the attitude to consent in research developing through
the principles of Helsinki which govern the ethics of
research) and secondly because the requirement for
the research community to be in a state of equipoise
when conducting trials means that appeals to the
principle of beneficence are less convincing in a research
context [13, 16, 17].
Perhaps following from this last point, it has been ar-
gued that where there is genuine equipoise as between
the existing and trial treatments, then therapeutic re-
search may not be significantly different, from an ethical
point of view, from clinical treatment [33]. If this is so,
then it is concluded that there should be no difference
in the nature of the ethical principles governing the two
practices [32, 33].
Likewise, it has been questioned whether, if there is in
fact an inclusion benefit for subjects who participate in
trials, research should be viewed as any different from
treatment [34]. However, it has also been claimed that
the stricter ethical guidelines in research correctly ac-
knowledge the altered doctor-patient relationship when
the subject is both a patient and a trial participant [34].
Finally, reverting more directly to issues of risk, it has
been claimed that randomised controlled trials are
needed specifically to protect patients from the use of
untested treatments—in other words, to protect them
from the risks associated with those treatments [23, 35].
It has also been held that using unproven therapies in
treatment would in itself be a violation of patient auton-
omy, presumably because it would make the gaining of
fully informed consent impossible because the risks
would be unknown [31].
Other options for consent
In light of the concerns regarding the possibility of gain-
ing fully valid informed consent for neonatal and peri-
natal trials, and yet the generally prevailing views in
both the empirical and the analytical research in favour
of getting at least some form of consent from parents,
analytical research has also discussed other ways of ad-
dressing the consent requirement. One claim defends the
idea of a waiver of consent in emergencies [18, 36–38],
but to this view can then be added (all or some of) a series
of constraints. Thus, it is suggested that consent can be
waived, but that provisional assent must be given at the
time of being invited to participate in the trial [37] and
that there should be community involvement at the design
stage for the trial protocol [30]. It is claimed that this wai-
ver procedure would not violate the principle of autonomy
[30]. However, the aim must be to make research possible
for the benefit of patients, and this waiver process should
not be used to make research easier for researchers [30].
A second approach defends a method by which pa-
tients’ consent is achieved through giving them antenatal
notification of the intended clinical trial and then seek-
ing consent if they meet the criteria for entry into the
trial [36, 38]. This process is purported to have the ad-
vantages of (1) allowing the potential subject extra time
to reflect on the information and arrive at a decision
[24], thus (2) aiding understanding and (3) reducing anx-
iety [36]. However, its disadvantages include the facts that
(1) there may be logistical problems in delivering the ne-
cessary information in this way [30, 37], (2) it places an
unnecessary burden on those who will not be eligible
[34, 37, 38], and (3) parents may not listen properly if
they assume they may not be the ones who will be affected
[34]. Proponents of this view claim that these disadvan-
tages can be mitigated by good communication skills [34].
A third option discussed within the analytical research
is that of deferred or continuing consent [18, 24, 37].
This is a process in which, if the parents are absent or
are affected by situational incapacity, they are assumed
to give initial consent and then actually provide full con-
sent when they are capable of taking in the information
and making the decision [18]. There is an important
objection to this suggestion, and this is that in it no one
actually consents to enrolment [18, 24], which also
leaves open the possibility that the subject will subse-
quently not consent, in which case the trial intervention
would have constituted assault.
However, full consent provides only ‘permission to
continue’. It cannot provide retrospective consent [18, 36].
Furthermore, such subsequent full consent is irrelevant
with regard to one-off interventions [30, 36] because it be-
comes redundant [18] (although it is still applicable to use
of personal data for research).
The concept of retrospective consent is considered in
the literature. However, this method is argued to be
‘logically incongruent’ [18]. Consent is not actually given,
so that, once again, if consent is retrospectively withheld,
the researcher is left in the position of never having had
consent and thus can be accused of having engaged in
assault on the subject.
Another option is the Zelen method of gaining con-
sent [12, 39]. In this approach, parents are not informed
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if the novel ‘intervention’ will not be offered to the child
[40, 41]. Thus, it is argued that this avoids any additional
distress [41] which arises for the parents, either from
participating in the consent process itself [12, 40] or
from knowing that they are in the control group [40].
But, it is argued, this method still respects the rights of
the family to know what is happening [12, 39]. One
might doubt whether this method deals fully with the
challenges for parents to achieve adequate understand-
ing, noted in the section on validity of consent above.
However, other concerns are also raised, namely that
there are statistical or methodological problems with the
method [35] and that the method really circumvents the
consent requirement rather than addressing it [35].
The final suggestion is the opt-out method for giving
consent. In this case, as the name suggests, the subject is
assumed to consent unless she or he explicitly opts out
of the trial. The advantages of this process are said to be
that it may lessen the burden on parents, it may increase
recruitment, and it may increase understanding [34].
However, the objections are that autonomy may be over-
ridden in such a process, such as if the subject fails to
exercise her opt-out right by default rather than really
opting out autonomously [34].
Defenders of this final proposed alternative method
suggest that this problem could be minimised by good
communication [34]. It is also argued that the loss of au-
tonomy at that stage (i.e., at the time of opting out) could
be ‘offset’ by continued discussion after the event. This
would ‘restore autonomy’ by giving more time for infor-
mation processing [34]. It has also been suggested that a
mixed method in which the potential subject is (1) pro-
vided with antenatal notification, then (2) given the right
to opt out of the research (but assumed to opt in if she or
he does not exercise that right), and (3) engaged in a fur-
ther process of continuing consent amounts as a whole to
a procedure of attaining ‘presumed consent’ [34].
Clearly, all these approaches involve a parent giving
(or waiving) consent, but a final alternative is to have a
consent process in which an independent proxy gives
consent for the child. However, it is claimed, against this
process of seeking consent, that it is difficult to find a truly
independent proxy [18]. It also is argued that there is a
need for a truly independent proxy to ensure that the in-
terests of potential trial participants are not conflated with
the interests of the research team or of the wider society,
or for that matter of some other wider group such as the
subject’s family [18]. It is also suggested that this form of
consent does not ‘feel’ as if it honours autonomy in the
same way as genuine consent does [18].
Discussion
What light, then, does the analytical literature cast on an
ethically defensible approach to obtaining informed
consent in perinatal clinical trials? We suggest that these
results reveal five key points about the consent process
and highlight one important gap in the research. The
key points are as follows:
 There are a variety of possible defences for seeking
parental ‘consent’ to neonatal and/or perinatal
clinical trials, and these are consistent with the
strongly and widely held view that it is important
that parents do give (or decline) consent for such
research, as found in the empirical literature [1].
 In giving parental ‘consent’ in a perinatal context,
parents are authorising infant participation, not
giving ‘proxy consent’.
 There are philosophical reasons for supposing that
at least some parents will fail to give valid consent
in a neonatal context. These support concerns about
the consent process that are raised in the empirical
literature.
 None of the existing consent processes reviewed by
the research is satisfactory. This matches the
findings of the empirical research.
 There are reasons for giving weight to both parental
‘consent’ and the infant’s best interests in both
research and clinical treatment, but also reasons to
treat these factors differently in the two contexts,
and this may be partly due to the differing relevance
of risk in each case.
There is also a significant gap in the philosophical lit-
erature, namely a lack of any detailed discussion of a
process of emergency and/or urgent assent followed by
later full consent, matching a gap found in the empirical
literature [1].
Now we take each key point in turn. There has been
considerable discussion over a number of years of the
justification for seeking parental consent to perinatal
and/or neonatal clinical trials. Firstly, the consensus of
argument suggests that this requirement is justified, but
there is not definite agreement on a single best account
of the justification. Secondly, if there is justification for
parental involvement, what is given does not count as
direct consent, because the child is not expressing a
view. Furthermore, the parental involvement is better
understood in relation to an analysis of the nature of
parenting in which the parent is permitting or authoris-
ing the child’s participation, than as the parent giving
proxy consent.
This second point relies on the idea that parenting
brings with it certain rights or duties, a responsibility to
take certain decisions about the child’s treatment. This
might be seen as a simple duty, not as requiring further
defence or, writers suggest, as something to be further
defended (1) in terms of the parental role in relation to
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the child’s best interests or (2) in terms of the fact that
the parents will have to deal with the consequences of
the way in which the child is treated. By contrast, whilst
a notion of proxy consent may apply in at least some cir-
cumstances where a child is not competent to consent,
in this case the child has not yet formed relevant beliefs
and values on the basis of which a proxy decision could
be made.
If, then, in the neonatal context, parents should be
seen not as giving ‘proxy’ consent but as authorising or
giving permission, how is this related to pursuit of the
child’s best interests? One argument, above, is that par-
ental ‘authorisation’ is justified because parents have a
special relation to the child’s best interests. However,
whilst there might be something in this, it is also noted
that in research the researcher and ethics review process
must take primary responsibility for the best interests of
subjects, so the parental contribution to protecting the
child’s interests should be, at most, secondary.
Given the problems parents often have in giving valid
consent in the context of neonatal clinical trials, why
might not the whole process of parental authorisation be
dispensed with and the issue considered entirely in
terms of the child’s best interests? Here the intersection
with the empirical literature appears particularly import-
ant. For the view of parental authorisation as in some
way part of a parent’s role coheres well with the widely
held view amongst parents that they should be con-
sulted, even if the process of consultation is imperfect by
the standards of ‘fully informed consent’. This supports
the need for a process which gives space to parental in-
volvement on behalf of the child.
Closely connected to this issue is our third claim,
which questions the validity of the consent process in
neonatal research. The research here provides arguments
explaining why a range of factors (e.g., temporal issues,
emotional disturbance or coercive circumstances) all
make an impaired consent process likely in this context.
This complements the empirical findings that concerns
about the consent process are warranted.
Our fourth point is equally consistent with those find-
ings. Although a variety of consent processes have been
considered or tried, there are reasons to find fault in
each of them. One response to this would be to suggest
that the weight given to consent in the research process
(as well as to best interests) should not differ from that
given to it in the clinical context, and this might allow it
to be dispensed with in certain circumstances. Our final
substantive conclusion drawn from the analytical litera-
ture is that a clinical intervention does differ from offer-
ing an infant participation in a clinical trial, and this
may be due to the role of risk in research. Thus, once
again, even if the process is imperfect, there is still rea-
son to seek parental consent for research.
Finally, there is one significant gap in the analytical re-
search. This gap concerns discussion of a new process
for seeking parental authorisation, one which acknowl-
edges that the circumstances of neonatal clinical trials
make fully informed consent at the outset impossible,
but which seeks to make the best room possible for par-
ental involvement. Considered reflection needs to be
given to this process, in which parents assent to or re-
fuse their baby’s participation as best they can during
the emergency and later give full consent to continuing
participation and follow-up.
Conclusions
Philosophical analysis supports empirical research in
several claims. It notes that it is important that parental
‘consent’ be sought for neonatal research participation,
but suggest this is better understood as parental ‘author-
isation’ of the participation. However, the analysis also
shows that this should be at best a secondary way of
protecting the child’s best interests. Furthermore, the
analysis gives reasons why at least some parents will fail
to give valid consent in a neonatal context, as no exist-
ing consent process has been found satisfactory. How-
ever, little detailed philosophical attention has been paid
to a possible new process for seeking parental authorisa-
tion, namely emergency and/or urgent assent followed
by later full consent.
Endnotes
1In philosophical work, this is sometimes arrived at by
using a mind-mapping technique.
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